Stevanato Group S.p.a. Stock
€25.00
Your prediction
Stevanato Group S.p.a. Stock
Pros and Cons of Stevanato Group S.p.a. in the next few years
Pros
Cons
News
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology